» Articles » PMID: 9733866

Identification of a Negative Cis Element Within the ZII Domain of the Epstein-Barr Virus Lytic Switch BZLF1 Gene Promoter

Overview
Journal J Virol
Date 1998 Sep 12
PMID 9733866
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The Epstein-Barr virus (EBV) lytic switch gene, BZLF1, is tightly regulated in latently infected B cells. The BZLF1 gene promoter (Zp) contains several cis elements that have been previously shown to respond to inducers of the viral lytic cycle. These include four copies of an element referred to as the ZI domains and an element that contains a consensus CRE/AP-1 motif (ZII domain). In addition, Zp is autoregulated through two sites that bind the BZLF1 gene product Zta. The ZI domains have been shown to bind the ubiquitous cellular transcription factors Sp1 and Sp3 and/or the myocyte enhancer factor 2D (Liu et al., EMBO J. 16:143-153, 1997; Liu et al., Virology 228:9-16, 1997). Here we present a functional analysis of the ZII domain and show: (i) ATF-1 and ATF-2 appear to be the predominant cellular factors that bind to the CRE/AP-1 motif present in the ZII domain; and (ii) the region immediately upstream of the CRE/AP-1 motif contains a potent negative cis element, mutation of which results in a >10-fold increase in Zp activity. The negative cis element (ZIIR) in the ZII domain decreases both basal and induced Zp activity and thus is likely to play an important role in regulating reactivation of EBV. In addition, analysis of heterologous promoter constructs indicates that the function of ZIIR is context sensitive. Attempts to demonstrate a cellular factor binding to ZIIR have been unsuccessful, leaving unresolved the mechanism by which repression is mediated.

Citing Articles

A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency.

Ward B, Prasai K, Schaal D, Wang J, Scott R PLoS Pathog. 2023; 19(12):e1011873.

PMID: 38113273 PMC: 10763950. DOI: 10.1371/journal.ppat.1011873.


Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation.

Murata T, Sugimoto A, Inagaki T, Yanagi Y, Watanabe T, Sato Y Viruses. 2021; 13(12).

PMID: 34960613 PMC: 8706188. DOI: 10.3390/v13122344.


Reactivation of Epstein-Barr Virus by HIF-1α Requires p53.

Kraus R, Cordes B, Sathiamoorthi S, Patel P, Yuan X, Iempridee T J Virol. 2020; 94(18).

PMID: 32641480 PMC: 7459560. DOI: 10.1128/JVI.00722-20.


Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.

Siddiqi U, Vaidya A, Li X, Marcon E, Tsao S, Greenblatt J J Virol. 2019; 93(20).

PMID: 31341047 PMC: 6798110. DOI: 10.1128/JVI.00989-19.


Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter.

Kraus R, Yu X, Cordes B, Sathiamoorthi S, Iempridee T, Nawandar D PLoS Pathog. 2017; 13(6):e1006404.

PMID: 28617871 PMC: 5487075. DOI: 10.1371/journal.ppat.1006404.


References
1.
zur Hausen H, ONEILL F, Freese U, Hecker E . Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature. 1978; 272(5651):373-5. DOI: 10.1038/272373a0. View

2.
Flemington E, Speck S . Epstein-Barr virus BZLF1 trans activator induces the promoter of a cellular cognate gene, c-fos. J Virol. 1990; 64(9):4549-52. PMC: 247926. DOI: 10.1128/JVI.64.9.4549-4552.1990. View

3.
Luka J, Kallin B, Klein G . Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology. 1979; 94(1):228-31. DOI: 10.1016/0042-6822(79)90455-0. View

4.
Kallin B, Luka J, Klein G . Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells. J Virol. 1979; 32(3):710-6. PMC: 525917. DOI: 10.1128/JVI.32.3.710-716.1979. View

5.
Bauer G, Hofler P, zur Hausen H . Epstein-Barr virus induction by a serum factor. I. Induction and cooperation with additional inducers. Virology. 1982; 121(1):184-94. DOI: 10.1016/0042-6822(82)90128-3. View